Inhaled Interventions in Cystic Fibrosis: Mucoactive and Antibiotic Therapies

Publisher： Karger

E-ISSN： 1423-0356|88|6|441-448

ISSN： 0025-7931

Source： Respiration, Vol.88, Iss.6, 2014-11, pp. : 441-448

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antibiotic-Resistant Pseudomonas aeruginosa in Cystic Fibrosis

By  

Respiration, Vol. 74, Iss. 3, 2007-01 ,pp. : 356-356

Karger

Access to resources Recommend Favorite

Breakthrough therapies: Cystic fibrosis (CF) potentiators and correctors

By  

PEDIATRIC PULMONOLOGY, Vol. 50, Iss. S40, 2015-10 ,pp. : S3-S13

John Wiley & Sons Inc

Access to resources Recommend Favorite

Safety and tolerability of inhaled hypertonic saline in young children with cystic fibrosis

By  

PEDIATRIC PULMONOLOGY, Vol. 43, Iss. 11, 2008-11 ,pp. : 1100-1106

John Wiley & Sons Inc

Access to resources Recommend Favorite

Candida albicans chronic colonisation in cystic fibrosis may be associated with inhaled antibiotics

By  

MYCOSES (ELECTRONIC), Vol. 58, Iss. 7, 2015-07 ,pp. : 416-421

John Wiley & Sons Inc

Access to resources Recommend Favorite

Outcomes of Adults with Cystic Fibrosis Infected with Antibiotic-Resistant Pseudomonas aeruginosa

By  

Respiration, Vol. 73, Iss. 1, 2006-02 ,pp. : 27-33

Karger

Access to resources Recommend Favorite